Home › Mga Problema sa Mata dahil sa Diabetes
Pag-aaral pangklinika para sa Mga Problema sa Mata dahil sa Diabetes na nagre-recruit sa U.S.
26 pag-aaral para sa Mga Problema sa Mata dahil sa Diabetes ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- San Antonio, TX4 pag-aaral
- San Francisco, CA3 pag-aaral
- Birmingham, AL3 pag-aaral
- Baltimore, MD3 pag-aaral
- Sacramento, CA3 pag-aaral
- Hagerstown, MD3 pag-aaral
- Austin, TX3 pag-aaral
- Houston, TX3 pag-aaral
- Bakersfield, CA3 pag-aaral
- Chicago, IL3 pag-aaral
- Carmel, IN3 pag-aaral
- Raleigh, NC3 pag-aaral
- Glendale, CA3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- Arizona3 pag-aaral
- California8 pag-aaral
- Florida8 pag-aaral
- Illinois4 pag-aaral
- Indiana3 pag-aaral
- Maryland6 pag-aaral
- North Carolina5 pag-aaral
- Ohio3 pag-aaral
- South Carolina4 pag-aaral
- Texas5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06321302A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07705607A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07588100Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06629649Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07592273A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07812090National Eye Institute Biorepository for Retinal Diseases
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT01496625Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 21 hanggang 98 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT03403699Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
Nagre-recruit
Edad 22 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06763952Intraoperative OCT Guidance of Intraocular Surgery II
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
4 Weeks · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT03713268Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for NAION
Nagre-recruitPhase 1
Lahat ng edad · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT05147701Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 22 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07844317Corticosteroid for Diabetic Macular Edema (DME) Study
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07843849Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 21 hanggang 98 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03403686ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Nagre-recruit
Edad 8 hanggang 21 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05463289Clinical Applications of Advanced Ophthalmic Imaging
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT03135327Biomarker of Diabetic Retinopathy
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT05079399Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT04505618Village-Integrated Eye Worker Trial II
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 60 pataas · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT03752840Strategies for Improving Linkage-to-Care After Eye Disease Screening
Nagre-recruit
Edad 60 pataas · Lahat ng kasarian · Na-update Abr 29, 2026 · NCT06943599Sleep, Diabetic Retinopathy and Melatonin
Nagre-recruitPhase 2
Edad 40 hanggang 65 · Lahat ng kasarian · Na-update Abr 21, 2026 · NCT04547439Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT07296952Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT04008121Assessment of AI Program 'DRISTi' as a Screening Tool
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 21 pataas · Lahat ng kasarian · Na-update Dis 9, 2025 · NCT07222293Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.